Page last updated: 2024-09-04

resiquimod and Carcinoma, Basal Cell

resiquimod has been researched along with Carcinoma, Basal Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benninghoff, B; Bong, AB; Drewniok, C; Geilen, CC; Gollnick, H; Herz, J; Reifenberger, J; Schön, M; Schön, MP; Slade, HB	1

Other Studies

1 other study(ies) available for resiquimod and Carcinoma, Basal Cell

Article	Year
Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. Journal of the National Cancer Institute, 2003, Aug-06, Volume: 95, Issue:15 Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Caspase 3; Caspases; Cytochrome c Group; DNA Fragmentation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Imiquimod; Immunologic Factors; In Situ Nick-End Labeling; Keratinocytes; Proto-Oncogene Proteins c-bcl-2; Receptors, Tumor Necrosis Factor; Tumor Cells, Cultured; Up-Regulation	2003

Article

Year

Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod.

Journal of the National Cancer Institute, 2003, Aug-06, Volume: 95, Issue:15

Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Caspase 3; Caspases; Cytochrome c Group; DNA Fragmentation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Imiquimod; Immunologic Factors; In Situ Nick-End Labeling; Keratinocytes; Proto-Oncogene Proteins c-bcl-2; Receptors, Tumor Necrosis Factor; Tumor Cells, Cultured; Up-Regulation

2003